Full-Time

Associate Software Engineer

SAP Extended Warehouse Management

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Entry, Junior

Norwood, MA, USA

70/30 work model requiring 70% in-office presence.

Category
Backend Engineering
Software Engineering
Required Skills
Inventory Management
SAP Products
Data Analysis
Requirements
  • Minimum 2 years of experience in the design, configuration and testing of solutions across an SAP system.
  • Specific experience in the following submodules: EWM and/or WM / HUM SAP modules, Inventory management (IM).
  • Experience with proposing functional solutions to developers when writing functional specs.
  • Familiarity of SAP S/4 is a plus.
  • Familiarity of a FDA regulated environment such as Pharma/Medical device is a plus.
Responsibilities
  • Partner with senior EWM System Engineers to define the best design and architecture of EWM.
  • Be the key point of contact for internal logistics business units.
  • Perform business analysis and SAP ERP S/4 system support of the supply chain units in a fast-paced clinical and commercial drugs manufacturing environment.
  • Support actual EWM solution.
  • Support clinical trial for our Personalized Cancer Vaccine and later commercial phase of it.
  • Support data analysis.
  • Write business design documents, functional specs, test scripts.
  • Support SAP projects to drive continuous improvement.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

15%

2 year growth

53%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?